Sermorelin possesses one of the most extensively characterized pharmacological profiles among GHRHR agonists, with well-documented receptor binding properties, signaling activity, and ligand-receptor interaction data
Pharma Direct Programs Lilly Direct Zepbound (Vial) - $299$499/month Indication: Weekly injection for chronic weight management in adults with obesity or overweight with weight-related conditions (including diabetes or obstructive sleep apnea), alongside diet and exercise Dosing: Starts at 2.5 mg weekly, titrated up to 15 mg Average weight loss: Up to ~20% of body weight at higher doses in clinical trials NovoCare Wegovy Injection - $499/month Indication: Chronic weight management for adults with BMI 30, or BMI 27 with weight-related conditions Also shown to reduce cardiovascular risk in certain patients Dosing: Weekly injections titrated from 0.25 mg to 2.4 mg Average weight loss: ~1415% of body weight in trials NovoCare Wegovy Oral Tablet - Starting at $149/month Indication: Chronic weight management for adults with obesity or overweight with at least one weight-related condition, alongside diet and exercise Dosing: 25 mg once daily Average weight loss: ~1317% of body weight in clinical studies Is Medical Weight Loss Right for You
They can be applied across multiple conditions, indications, and patient journeys
Lin CC, Mabe NW, Lin YT, Yang WH, Tang X, Hong L, et al
10.2337/db11-0936 27 OverbeekJ
Stimulation of the adrenal gland in primary disease will not result in the release of cortisol
